Please login to the form below

Not currently logged in
Email:
Password:

Oxford BioDynamics

This page shows the latest Oxford BioDynamics news and features for those working in and with pharma, biotech and healthcare.

Latest appointments

  • Paul Stockdale joins Oxford BioDynamics as CFO Paul Stockdale joins Oxford BioDynamics as CFO

    He takes over from Katie Long, who has returned to her role within Tessera Investment Management, having previously established and led Oxford BioDynamics’ finance function. ... A spin-out from Oxford University, Oxford BioDynamics focuses on the

  • Martin Reeves joins Oxford BioDynamics Martin Reeves joins Oxford BioDynamics

    He takes up a senior vice president role. Oxford BioDynamics – a spin out company from the University of Oxford – has appointed Martin Reeves as its new senior vice president, commercial development. ... Christian Hoyer Millar, CEO at Oxford

  • Caldan Therapeutics bolsters senior team Caldan Therapeutics bolsters senior team

    Dr Boyd currently serves as chief financial officer at private life sciences companies Oxford BioDynamics and Enterprise Therapeutics, and was interim-chief financial officer for Tiziana Pharmaceuticals between 2014 and 2015.

More from appointments
Approximately 2 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
90TEN Healthcare

90TEN is an award-winning healthcare communications consultancy that puts people at the heart of everything we do. Our Life.Changing. campaigns...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics